Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
21 February 2014 09:50
Clinical trials were carried out in vivo as well as in vitro
A new drug which selectively kills dormant cancer cells has been tested by scientists.
The molecule works by inducing dysfunction in mitochondria - the powerhouse of cells.
The research, conducted by Prof Stig Linder of the Swedish Karolinska Instituet and Uppsala University, found that a small molecule named VLX600 has been proven ineffective in killing dormant colon cancer cells in a variety of models, including in clinical trials and in test subjects with the medical condition.
Experts say that in solid tumours larger than a few millimetres, a lack of oxygen and nutrients is common as a result of insufficient growth in the blood vessels. This can cause cancer cells to remain dormant - and even after they receive treatment, they can divide, causing tumours to grow. This process helps cancers resist radiotherapy and chemotherapy.
The study shows that in these tumour areas that lack oxygen and nutrition, there is a lack of mitochondrial energy production for which the cancer cells cannot compensate. The researchers said: "Our ?ndings suggest that tumour cells in nutritionally compromised microenvironments are sensitive to disturbances of mitochondrial function, resulting in a bioenergetic catastrophe."
The VLX600 molecule was found to cause this dysfunction in mitochondria, causing colon cancer cells to die. When the substance was tested on colon cancer cell lines in vivo, it suppressed tumour growth. The molecule also helped boost other anti-cancer drugs, such as irinotecan.
The study leaders said: "Our ?ndings suggest that tumour cells in metabolically compromised microenvironments have a limited ability to respond to decreased mitochondrial function, and suggest a strategy for targeting the quiescent populations of tumour cells for improved cancer treatment."
People can find more information about travel insurance for cancer patients here.
19 April 2018
A self-injected smart drug may be the key to easing and preventing pain for migraine sufferers.
[more...]
17 April 2018
Despite its reputation as a party drug, ketamine is licensed as an anaesthetic. A recent US study found use of the drug via a nasal spray led to "significant" improvements in depressive symptoms in the first 24 hours.
Simple brain-training exercises carried out at home have been shown to reduce emotional stress in female breast cancer survivors, it's recently been revealed.
13 April 2018
Drinkers who consume more alcohol than UK guidelines suggest could be cutting years off their lives, according to new research.
12 April 2018
A recent study has revealed that people who sustain brain injuries are at an increased risk of developing dementia later in life.
11 April 2018
Scientists have announced their latest breakthrough in the battle against Alzheimer's disease, after neutralising a high-risk gene in a human brain cell for the first time.
07 April 2018
The Philippines is set to shut its most famous holiday island of Boracay for six months, after the President described it as a "cesspool".
05 April 2018
Taxes on soft drinks, alcohol and tobacco - nicknamed "sin taxes" - could be a powerful step towards combating rising rates of chronic diseases worldwide, research has suggested.
New "one-stop shops" to speed up cancer diagnosis are being trialled across the country for the first time.
30 March 2018
Doctors should tell patients that e-cigarettes are less harmful than smoking but not without risk, according to new national guidance.
29 March 2018
Young people suffering from mental health problems are finding it hard to get the support they need, a survey has revealed.
28 March 2018
Children exposed to epilepsy drugs in the womb may achieve poorer test results at school, a study has suggested.